Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F F Marshall

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Urology|February 1, 1995
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volumeA W Partin, S R Criley, M S Steiner, et al.
Journal of the National Cancer Institute|July 19, 1989
Specific genetic change in tumors associated with von Hippel-Lindau diseaseK Tory, H Brauch, M Linehan, et al.
The Journal of Urology|December 17, 2009
Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinomaT V Johnson, A Abbasi, A Owen-Smith, et al.
Journal of Endourology|July 16, 1999
Laparoscopic renal cryoablation: acute and long-term clinical, radiographic, and pathologic effects in an animal model and application in a clinical trialJ T Bishoff, R B Chen, B R Lee, et al.
Anticancer Research|March 26, 2002
Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epitheliumC D Donald, A Laddu, P Chandham, et al.
Urology|March 12, 1998
Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancerA A Baccala, H Zhong, S M Clift, et al.
The American Journal of Pathology|May 5, 2001
Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markersA N Young, M B Amin, C S Moreno, et al.
Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.
European Urology|January 1, 1990
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapyW B Isaacs, J T Isaacs, N Kyprianou, et al.
Oncogene|February 22, 2007
cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasisD Wu, H E Zhau, W-C Huang, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Urology|February 1, 1995
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volumeA W Partin, S R Criley, M S Steiner, et al.
Journal of the National Cancer Institute|July 19, 1989
Specific genetic change in tumors associated with von Hippel-Lindau diseaseK Tory, H Brauch, M Linehan, et al.
The Journal of Urology|December 17, 2009
Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinomaT V Johnson, A Abbasi, A Owen-Smith, et al.
Journal of Endourology|July 16, 1999
Laparoscopic renal cryoablation: acute and long-term clinical, radiographic, and pathologic effects in an animal model and application in a clinical trialJ T Bishoff, R B Chen, B R Lee, et al.
Anticancer Research|March 26, 2002
Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epitheliumC D Donald, A Laddu, P Chandham, et al.
Urology|March 12, 1998
Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancerA A Baccala, H Zhong, S M Clift, et al.
The American Journal of Pathology|May 5, 2001
Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markersA N Young, M B Amin, C S Moreno, et al.
Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.
European Urology|January 1, 1990
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapyW B Isaacs, J T Isaacs, N Kyprianou, et al.
Oncogene|February 22, 2007
cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasisD Wu, H E Zhau, W-C Huang, et al.
Pageof 17